Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-25-016865

EVP, Chief Commercial Officer sold 8,659 shares at $32.04 ($277,434)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Callos Andrew · EVP, Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-05 Sale : show line 1 in the form 10b5-1 −8,659 $32.04 $277,434 52,028 D
Open-market sales · 8,659 sh · avg $32.04 · $277,434
Loading xslF345X05/form4.xml…